Animal Nutrition & Health

Erratum Statement on our communication relating to the new European authorization of Hy-D®

In our Nutri.Mail of 25/04/2024 on the latest developments on the legislation with respect to the new European approval of Hy-D® among other products unfortunately a redactional error was made. In this message it was wrongfully stated that the common use of Hy-D® with other sources of 1,25 (OH)2cholecalciferol from Solanum glaucophylum (eg. Panbonis) is prohibited by law.

However, this is not correct. The EU 2024/1070 statement does not refer to "Solanum glucophylum" itself, but explicitely to Solanum glaucophylum extract.

The correct phrasing should have been:
Please be aware that the European Commission specifies in the conditions of application that the common use of Hy-D® with glycosilated met 1,25 dihydroxycholecalciferol derived from Solanum glaucophylum extract is not allowed.

Therefore, in contrast to what we previously stated, Panbonis can be applied in combination with Hy-D® in poultry, swine and ruminants.”

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.
www.dsm-firmenich.com

Published on

05 September 2024

Tags

  • Special Nutrients
  • Hy-D

Share

You are being redirected.

We detected that you are visitng this page from United States. Therefore we are redirecting you to the localized version.